Ebos Group (NZSE:EBO) 3-Year FCF Growth Rate : 1.90% (As of Jun. 2024)

View and export this data going back to 1960. Start your Free Trial

What is Ebos Group 3-Year FCF Growth Rate?

Ebos Group's Free Cash Flow per Share for the six months ended in Jun. 2024 was NZ$1.10.

During the past 12 months, Ebos Group's average Free Cash Flow per Share Growth Rate was -10.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 1.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 15.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Ebos Group was 64.70% per year. The lowest was -40.90% per year. And the median was 9.20% per year.

Competitive Comparison of Ebos Group's 3-Year FCF Growth Rate

For the Medical Distribution subindustry, Ebos Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's 3-Year FCF Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Ebos Group's 3-Year FCF Growth Rate falls into.

Ebos Group 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Ebos Group (NZSE:EBO) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Ebos Group 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Ebos Group's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

EBO:Australia

Address

737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group Headlines

No Headlines